On Aug. 10, the FDA said 4,586 devices were recalled because of sudden power failures, which can cause inadequate blood supply and death. Twenty-six complaints, zero injuries and zero deaths have been reported in the recall.
This is the fourth statement the FDA has published in 2023 about the devices. In February, the company notified customers to stop using the pumps because of unexpected shutdowns, the FDA said in separate posts.
The month prior, the FDA said Getinge/Datascope reported a risk of balloons breaking. As of Jan. 25, 134 complaints, 12 device shutdowns, four serious injuries and one death have been reported.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.